高级检索
廖佩花, 马彦清, 曾同霞, 陈波, 杨磊, 李锋, 何玲, 秦江梅. 哈萨克族食管癌与HLA-DR9等位基因关系[J]. 中国公共卫生, 2009, 25(7): 798-800. DOI: 10.11847/zgggws2009-25-07-16
引用本文: 廖佩花, 马彦清, 曾同霞, 陈波, 杨磊, 李锋, 何玲, 秦江梅. 哈萨克族食管癌与HLA-DR9等位基因关系[J]. 中国公共卫生, 2009, 25(7): 798-800. DOI: 10.11847/zgggws2009-25-07-16
LIAO Pei-hua, MA Yan-qing, ZENG Tong-xi, . Case-control study of HLA-DR9 gene polymorphism and genetic factors of esophageal cancer in Kazakh[J]. Chinese Journal of Public Health, 2009, 25(7): 798-800. DOI: 10.11847/zgggws2009-25-07-16
Citation: LIAO Pei-hua, MA Yan-qing, ZENG Tong-xi, . Case-control study of HLA-DR9 gene polymorphism and genetic factors of esophageal cancer in Kazakh[J]. Chinese Journal of Public Health, 2009, 25(7): 798-800. DOI: 10.11847/zgggws2009-25-07-16

哈萨克族食管癌与HLA-DR9等位基因关系

Case-control study of HLA-DR9 gene polymorphism and genetic factors of esophageal cancer in Kazakh

  • 摘要: 目的 探讨人类白细胞抗原DR9 (HLA-DR9)等位基因与新疆哈萨克族食管癌的相关性.方法 采用1:2成组匹配病例对照研究,共收集哈萨克族食癌新发病例170例,对照340人,进行问卷调查,并采静脉血3mL检测HLA-DR9等位基因频率;采用Logistic回归模型及交互作用进行统计分析.结果 病例组和对照组HLA-DR9等位基因频率分别为22.9%,9.1%,差异有统计学意义 (χ2=18.29,P=0.000,OR=2.97);病例组和对照组有食管或胃病变史分别占26.5%,12.9%,差异有统计学意义 (χ2=14.40,P=0.000,OR=2.42);病例组和对照组有食管癌家族史者分别占18.20%,8.80%,差异有统计学意义 (χ2=9.53,P=0.002,OR=2.31).Logistic回归分析及交互作用显示,HLA-DR9等位基因、食管或胃病变史以及食管癌家族史是哈萨克族食管癌的危险因素,且后2者均与HLA-DR9等位基因存在交互作用.结论 HLA-DR9等位基因为哈萨克族食管癌的易感基因,与食管或胃病变、食管癌家族史之间存在交互作用.

     

    Abstract: Objective To evaluate the association between HLA-DR9 genetic polymorphisms and esophageal cancer (EC) in a Kazakh population of high incidence area at Xinjiang,China.Methods A case-control study was conducted with 170 EC cases and 340 controls.HLA-DR9 was identied by PCR-SSP.Logistic regression model was performed to identify fisk factors.The strata method was adopted in interaction analysis.Results The frequency of HLA-DR9 gene in the cases and controls were 22.9% and 9.1%,respectively,with significant difference (χ2=18.29,P=0.000,OR=2.97).The genotype frequncy of esophageal cancer was different from that of the controls (χ2=18.29,P=0.000;OR=2.97,95% Cl:1.78-4.96).The proportion of history of esophageal or stomach disease in esophageal cancer group was 26.5%,while the proportion was 12.9% in the controls (OR:2.42,95% Cl:1.52-3.86).Family history of esophageal cancer was 18.20% in cases,while the proportion was 8.80% in the controls (OR:2.31,95% Cl:1.34-3.96).Multivariate Logistic regression analysis showed that HLA-DR9 genotype,history of esophageal or stomach disease and family history of esophageal cancer were risk factors of esophageal cancer.Gene-environment interaction analysis showed there was an interaction of HLA-DR9 genotype with history of esophageal or stomach disease and family history of esophageal cancer.Conclusion The HLA-DR9 genotype,history of esophageal or stomach disease and family history of esophageal cancer are important risk for EC,and there is a synergistic interation between HLA-DR9 gene and the history of esophageal or stomach disease and family history of esophageal cancer.HLA-DR9 gene can be used as biomarker for prevention of EC in Kazakh population.

     

/

返回文章
返回